tyrosine has been researched along with Angor Pectoris in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 15 (75.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhtari, S; Chandran, V; Colaco, K; Cook, RJ; Eder, L; Gladman, DD; Harvey, P; Lee, KA; McInnes, IB; Piguet, V; Sattar, N; Welsh, P; Winer, R | 1 |
| Coner, A; Müderrisoğlu, H; Okyay, K; Yıldırır, A | 1 |
| Braunwald, E; Cannon, CP; Demopoulos, LA; DiBattiste, PM; Gibson, CM; McCabe, CH; Morrow, DA; Murphy, SA; Sabatine, MS | 1 |
| Bonz, AW; Ertl, G; Held, S; Jacobs, M; Lengenfelder, B; Strotmann, J; Voelker, W | 1 |
| Bestehorn, HP; Bollwein, H; Dirschinger, J; Kastrati, A; Mehilli, J; Neumann, FJ; Pogatsa-Murray, G; Schmitt, C; Schömig, A; Seyfarth, M | 1 |
| DiBattiste, PM; Jang, IK; Januzzi, JL; Servoss, SJ; Snapinn, SM; Theroux, P; Wan, Y; Zhao, XQ | 1 |
| Ardissino, D; Bilheimer, DW; Blazing, MA; Braunwald, E; Califf, RM; de Lemos, JA; DiBattiste, PM; Fox, KA; Gardner, LH; Hasselblad, V; Lewis, EF; Palmisano, J; Pfeffer, MA; Ramsey, KE; Snapinn, SM; Verheugt, FW; White, HD | 1 |
| Angioli, P; Baldassarre, S; Bolognese, L; Burali, A; Ducci, K; Falsini, G; Liistro, F | 1 |
| Antman, EM; Braunwald, E; Cannon, CP; Morrow, DA; Sabatine, MS; Theroux, P | 1 |
| Akbulut, M; Arslan, N; Dagli, N; Durukan, P; Gundogdu, O; Ilkay, E; Ozbay, Y | 1 |
| Berger, PB; DiBattiste, PM; Lennon, R; Lubbe, D; Orford, JL; Talreja, D | 1 |
| Baum, H; Braun, S; Dibra, A; Dirschinger, J; Hadamitzky, M; Kastrati, A; Mehilli, J; Schömig, A; Schühlen, H | 1 |
| Barutcu, I; Boztosun, B; Gunes, Y; Kirma, C | 1 |
| Cay, S; Korkmaz, S; Topaloğlu, S | 1 |
| Barr, E; Becker, ER; Boccuzzi, SJ; Burnette, J; Cannon, CP; Cohen, DJ; Culler, SD; Demopoulos, L; Ellis, SG; Feeny, D; Kosinski, A; Krumholz, H; Mahoney, E; Robertson, D; Spertus, JA; Weintraub, WS | 1 |
| Hensley, S | 1 |
| Depre, C; Havaux, X; Renkin, J; Vanoverschelde, JL; Wijns, W | 1 |
| Droullé, C; Garnotel, R; Hézard, N; Metz, D; Nguyen, P; Potron, G | 1 |
| Goldberg, L; Mekel, J | 1 |
1 review(s) available for tyrosine and Angor Pectoris
| Article | Year |
|---|---|
[Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation].
Topics: Abciximab; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Blood Platelets; CD18 Antigens; Chemotaxis, Leukocyte; Coronary Artery Bypass; Coronary Disease; Cytokines; Fibrinogen; Heparin; Humans; Immunoglobulin Fab Fragments; Leukocytes; Ligands; Macrophage-1 Antigen; Membrane Glycoproteins; Models, Biological; Myocardial Infarction; Neutrophils; P-Selectin; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombospondins; Tirofiban; Tyrosine | 2000 |
7 trial(s) available for tyrosine and Angor Pectoris
| Article | Year |
|---|---|
Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservati
Topics: Acute Disease; Aged; Angina Pectoris; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Fees, Pharmaceutical; Female; Fibrinolytic Agents; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Severity of Illness Index; Smoking; Statistics as Topic; Stroke Volume; Survival Analysis; Syndrome; Tirofiban; Tyrosine | 2002 |
Cytokine response after percutaneous coronary intervention in stable angina: effect of selective glycoprotein IIb/IIIa receptor antagonism.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; C-Reactive Protein; Coronary Disease; Cytokines; Double-Blind Method; Humans; Inflammation; Interleukin-1; Interleukin-6; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Tirofiban; Troponin; Tumor Necrosis Factor-alpha; Tyrosine | 2003 |
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Myocardial Revascularization; Platelet Aggregation Inhibitors; Preoperative Care; Risk; Stents; Ticlopidine; Tirofiban; Treatment Outcome; Troponin T; Tyrosine | 2003 |
Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial.
Topics: Acute Disease; Angina Pectoris; Coronary Artery Bypass; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Myocardial Infarction; Myocardial Ischemia; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
Topics: Aged; Angina Pectoris; Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS).
Topics: Acute Disease; Angina Pectoris; Female; Fibrinolytic Agents; Heparin; Humans; Male; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial.
Topics: Angina Pectoris; Cost-Benefit Analysis; Drug Costs; Economics, Medical; Fibrinolytic Agents; Hospital Costs; Humans; Quality of Life; Relative Value Scales; Surveys and Questionnaires; Tirofiban; Treatment Outcome; Tyrosine | 1999 |
12 other study(ies) available for tyrosine and Angor Pectoris
| Article | Year |
|---|---|
Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis.
Topics: Adult; Alanine; Angina Pectoris; Apolipoproteins B; Arthritis, Psoriatic; Cardiovascular Diseases; Cholesterol; Fatty Acids, Unsaturated; Female; Heart Failure; Humans; Ischemic Attack, Transient; Lipoproteins, HDL; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Prospective Studies; Psoriasis; Risk Assessment; Stroke; Tyrosine | 2021 |
Management of myocardial infarction related to in situ thrombosis.
Topics: Angina Pectoris; Coronary Angiography; Coronary Thrombosis; Diagnosis, Differential; Female; Fibrinolytic Agents; Heparin; Humans; Middle Aged; Myocardial Infarction; Thrombectomy; Tirofiban; Tyrosine | 2013 |
Elevations in troponin I after percutaneous coronary interventions are associated with abnormal tissue-level perfusion in high-risk patients with non-ST-segment-elevation acute coronary syndromes.
Topics: Abciximab; Acute Disease; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Biomarkers; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Circulation; Electrocardiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Aggregation Inhibitors; Prospective Studies; Risk; Ticlopidine; Tirofiban; Troponin I; Tyrosine; Ultrasonography | 2004 |
Effects of tirofiban on acute systemic inflammatory response in elective percutaneous coronary interventions.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon; C-Reactive Protein; Coronary Angiography; Female; Fibrinogen; Follow-Up Studies; Humans; Interleukin-1; Interleukin-6; Interleukin-8; Leukocyte Count; Male; Middle Aged; Myocardium; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Tirofiban; Troponin; Tumor Necrosis Factor-alpha; Tyrosine | 2004 |
Does clopidogrel increase the degree of platelet inhibition when a platelet glycoprotein IIb/IIIa inhibitor has been given? Insights from an optical platelet aggregometry study.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Clopidogrel; Drug Combinations; Drug Interactions; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Tirofiban; Tyrosine | 2004 |
Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
Topics: Abciximab; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Biomarkers; C-Reactive Protein; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Heparin; Humans; Immunoglobulin Fab Fragments; Inflammation; Male; Middle Aged; Postoperative Period; Premedication; Stents; Ticlopidine; Tirofiban; Tyrosine | 2005 |
Successful lysis of coronary thrombi by long term warfarin treatment after a failed course of tirofiban infusion.
Topics: Angina Pectoris; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Enoxaparin; Female; Humans; Infusion Pumps; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Tirofiban; Treatment Failure; Treatment Outcome; Tyrosine; Warfarin | 2006 |
Acute coronary embolism after mitral valve replacement in a patient presenting with non-ST-segment elevation myocardial infarction.
Topics: Adult; Angina Pectoris; Coronary Angiography; Coronary Thrombosis; Diagnosis, Differential; Electrocardiography; Fibrinolytic Agents; Heart Conduction System; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 2006 |
New drugs blast budgets. Patients benefit; hospital pharmacies weigh options.
Topics: Abciximab; Angina Pectoris; Antibodies, Monoclonal; Anticoagulants; Drug Approval; Drug Costs; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Pharmacy Service, Hospital; Tirofiban; Tyrosine; United States; United States Food and Drug Administration | 1998 |
Expression of inducible nitric oxide synthase in human coronary atherosclerotic plaque.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Coronary Artery Disease; Coronary Vessels; Female; Humans; Immunohistochemistry; Macrophages; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Tumor Necrosis Factor-alpha; Tyrosine | 1999 |
Role of tirofiban in the medical treatment of the intermediate-risk patient with an acute coronary syndrome cannot be denied.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Confidence Intervals; Coronary Angiography; Double-Blind Method; Fibrinolytic Agents; Heparin; Humans; Incidence; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Tirofiban; Treatment Outcome; Tyrosine | 2000 |
Eptifibatide and tirofiban: new preparations. Limited benefit.
Topics: Angina Pectoris; Antibodies, Monoclonal; Clinical Trials as Topic; Cost-Benefit Analysis; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Risk Factors; Treatment Outcome; Tyrosine | 2000 |